Skip to main content
OpenTrials

Clinical trial condition

Diabetes Mellitus, Type 2

Explore clinical trials studying Diabetes Mellitus, Type 2. Study availability and eligibility vary by location and protocol.

2,679 public trials 155 recruiting studies
Refine in advanced search Browse all conditions

Diabetes Mellitus, Type 2 trial results

Completed

Comparison of NN1250 With Insulin Glargine in Type 2 Diabetes

NCT01006291

Conditions
Diabetes, Diabetes Mellitus, Diabetes Mellitus, Type 2, +4 more
Locations
  • Novo Nordisk Investigational Site Buenos Aires, Argentina
  • Novo Nordisk Investigational Site Buenos Aires, Argentina
  • Novo Nordisk Investigational Site Ciudad Autónoma de Bs As, Argentina
  • Novo Nordisk Investigational Site Rosario, Argentina
View all 72 locations
View Trial Details
Completed

Comparison of NN5401 Versus Biphasic Insulin Aspart 30 on a Twice Daily Regimen in Subjects With Type 2 Diabetes Mellitus

NCT00842361

Conditions
Diabetes, Diabetes Mellitus, Diabetes Mellitus, Type 2, +4 more
Locations
  • Novo Nordisk Investigational Site Chuo-ku, Tokyo, Japan
  • Novo Nordisk Investigational Site Miyazaki, Japan
  • Novo Nordisk Investigational Site Naka-shi, Ibaraki, Japan
  • Novo Nordisk Investigational Site Ota-ku, Tokyo, Japan
View Trial Details
Completed

Comparison of NN1250 Versus Insulin Glargine in Subjects With Type 2 Diabetes

NCT00982644

Conditions
Diabetes, Diabetes Mellitus, Diabetes Mellitus, Type 2, +4 more
Locations
  • Novo Nordisk Investigational Site Bay Minette, Alabama, United States
  • Novo Nordisk Investigational Site Birmingham, Alabama, United States
  • Novo Nordisk Investigational Site Huntsville, Alabama, United States
  • Novo Nordisk Investigational Site Goodyear, Arizona, United States
View all 187 locations
View Trial Details
Completed

Efficacy and Safety of Liraglutide Versus Lixisenatide as add-on to Metformin in Subjects With Type 2 Diabetes

NCT01973231

Conditions
Diabetes, Diabetes Mellitus, Diabetes Mellitus, Type 2, +4 more
Locations
  • Novo Nordisk Investigational Site Hradec Králové, Czechia
  • Novo Nordisk Investigational Site Mladá Boleslav, Czechia
  • Novo Nordisk Investigational Site Olomouc, Czechia
  • Novo Nordisk Investigational Site Pilsen, Czechia
View all 61 locations
View Trial Details
Completed

Clinical Evaluation of BD NEXT Pen Needle

NCT01852136

Conditions
Autoimmune Diseases, Diabetes Mellitus, Diabetes Mellitus, Type 1, +8 more
Locations
  • Physicians Research Center Toms River, New Jersey, United States
  • Mountain Diabetes and Endocrine Center Asheville, North Carolina, United States
  • Holston Medical Group Kingsport, Tennessee, United States
  • Corporation Lane Internal Medicine and Research Center Virginia Beach, Virginia, United States
View Trial Details

Related conditions